Post by AGC Biologics

Single-use technologies (SUTs) have become increasingly flexible and efficient. To help ensure consistent performance and long-term success, a comprehensive risk management strategy should be implemented from day #1. SUT experts, Andrew S. and Neel Gosaliya of AGC Biologics, explain how to identify and mitigate risk in SUT manufacturing in this article ⬇️  #SingleUseTechnologies #Biopharma #yourfriendlyCDMOexpert